Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Phosphoric Acid | HCID 1004 | — |
| Reactant | HCID 69058107 | HCID 69058107 | — |
| Solvent | Ethanol | HCID 702 | — |
| Product | HCID 69063038 | HCID 69063038 | — |
Reaction Steps
1.0 g (1.58 mmol) 4-(1,2,4,5-tetrahydro-2-oxo-3H-1,3-benzodiazepin-3-yl)-(1R)-1-[(4-hydroxy-3,5-dimethylphenyl)methyl]-2-[4-(4-morpholinyl)-1-piperidinyl]-2-oxoethyl 1-piperidinecarboxylate are dissolved in 8.9 ml boiling ethanol and combined with a solution of 106 μl phosphoric acid (85% in water) in 1.06 ml of ethanol. The mixture is stirred for 2 hours at 72° C., whereupon a white suspension is formed. After cooling the suspension is stirred for 12 hours at ambient temperature. The crystals formed are filtered off and dried for 12 hours at 40° C.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US07638625B2 |
|---|
| Source dataset | uspto-grants-2009_12 |
|---|
| ORD ID | ord-0c7a542319a44ae0870823e2e6140801 |
|---|
| Source note | uspto-grants-2009_12 |
|---|